Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Primary effusion lymphoma
ADR ID BADD_A10758
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.01      B-cell lymphomas NEC
01.15.01.010      Primary effusion lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.01      B-cell lymphomas NEC
16.28.01.010      Primary effusion lymphoma
Description A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency. [MeSH]
MedDRA Code 10065857
MeSH ID D054685
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Primary effusion lymphoma | Lymphoma, Primary Effusion | Effusion Lymphoma, Primary | Effusion Lymphomas, Primary | Lymphomas, Primary Effusion | Primary Effusion Lymphomas | Primary Effusion Lymphoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00589Dasatinib0.000224%
BADD_D02105Tacrolimus0.000446%
The 1th Page    1    Total 1 Pages